1h Free Analyst Time
The Medicated Confectionery Market size was estimated at USD 5.95 billion in 2022, USD 6.28 billion in 2023, and is expected to grow at a CAGR of 6.01% to reach USD 9.50 billion by 2030. Speak directly to the analyst to clarify any post sales queries you may have.
Medicated confectionery refers to a niche category of confectionery products that incorporate active pharmaceutical ingredients meant to alleviate various minor health ailments. These edible items blend the enjoyment of a sweet treat with the functionality of medication, offering consumers a more palatable intake than traditional medicinal products. This segment includes products such as cough drops, throat lozenges, antacid candies, and herbal-infused sweets. These confections typically aim to provide relief from symptoms such as sore throats, coughs, colds, digestive issues, and even nasal congestion. The incorporation of medicinal components, including menthol, eucalyptus oil, peppermint oil, and other herbal extracts, is common, and these are often carefully dosed to ensure both efficacy and safety. Medicated confectionery is primarily used for personal care and healthcare. It is purchased by consumers seeking relief from cold and flu symptoms, sore throats, coughs, or those requiring supplemental vitamins and minerals. Target end-users range from children to the elderly, often preferring these accessible forms over traditional medication due to ease of use and palatable flavors. Medicated confectionery market is growing due to the growing focus on health and wellness, expanding demand for fortified or functional confectionery products, rising demand for active ingredients in confectionery, and increasing cases of allergy and hay fevers. However, the market faces certain challenges, such as a limited adoption rate due to misconceptions about medicated confectioneries and volatility in raw material prices of medicated confectionery ingredients, hindering market growth. On the other hand, innovations in flavor and health ingredients, rising investments in research and development activities, online retailing and wide availability in supermarkets and pharmacies, and collaborating with health apps and platforms to promote medicated confectionery as part of a holistic health regimen are expected to support the medicated confectionery market to grow.
Regional Insights
In the Americas, with a focus on the United States and Canada, the medicated confectionery market thrives due to the high consumer demand for over-the-counter (OTC) throat soothers and mouth fresheners. The U.S. exhibits robust spending on healthcare products, with a tendency toward self-medication for minor ailments, which includes a rise in the purchase of medicated confectionery as a preventive measure. The ongoing urbanization in South America has led to busier lifestyles, where convenience is paramount, and medicated confections are favored for their ease of use and portability. The European Union (EU) market shows a trend towards functional confectionery, blending the lines between health supplements and candies. With a growing preference for natural ingredients, there is a surge in organic and sugar-free offerings in medicated candies across EU countries. Market campaigns often emphasize the health benefits and convenience of such products. The Middle East and Africa (MEA) present emerging markets with an expanding consumer base for medicated confectionery. Consumer concerns about diabetes and general health propel the need for sugar-free alternatives. Innovations and investments are typically geared towards tailoring flavors and ingredients to suit local tastes and dietary restrictions. The APAC countries, including China, Japan, and India, showcase diverse market dynamics in the medicated confectionery sector. China's growing middle class and increased health awareness drive the demand for medicated sweets. Japan's aging population and penchant for functional foods contribute to the market growth, while in India, the prevalence of sore throat-related ailments and a burgeoning youth population fuel the demand for affordable OTC remedies.FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Medicated Confectionery Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Medicated Confectionery Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.Key Company Profiles
The report delves into recent significant developments in the Medicated Confectionery Market, highlighting leading vendors and their innovative profiles. These include A.L.Simpkin & Co. Ltd., Baker Perkins Limited by Schenck Process Group, Bartek Ingredients Inc., Cargill, Inc., Creasy Foods Ltd., Enorama Pharma AB, Ernest Jackson Ltd., GelStat Corporation, Glanbia PLC, Hamac Food Industries Sdn Bhd, Herbion International Inc. by Kehkashan Group, Lofthouse of Fleetwood Ltd., Lozen Pharma Pvt. Ltd., Lozy's pharmaceuticals, S.L., Mars Incorporated, Mondelez International, Inc., Nestlé S.A. BY Ferrero International S.A., Perfetti Van Melle Group B.V., Piedmont Candy Company, Prince Group, Reckitt Benckiser Group PLC, Skyepharma Production S.A.S., Swan Sweets Pvt. Ltd, Syntegon Technology GmbH, Tereos S.A., and UHA Mikakuto Co.Ltd.Market Segmentation & Coverage
This research report categorizes the Medicated Confectionery Market to forecast the revenues and analyze trends in each of the following sub-markets:- Type
- Chewing Gums
- Hard Boiled Candies
- Pastilles
- Labeling
- Conventional
- Sugar-free
- Distribution Channel
- Convenience Stores
- Online Retail
- Specialist Stores
- Supermarkets & Hypermarkets
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report offers valuable insights on the following aspects
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as
- What is the market size and forecast of the Medicated Confectionery Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Medicated Confectionery Market?
- What are the technology trends and regulatory frameworks in the Medicated Confectionery Market?
- What is the market share of the leading vendors in the Medicated Confectionery Market?
- Which modes and strategic moves are suitable for entering the Medicated Confectionery Market?
Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report
Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.
This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.
Table of Contents
1. Preface
2. Research Methodology
4. Market Overview
5. Market Insights
6. Medicated Confectionery Market, by Type
7. Medicated Confectionery Market, by Labeling
8. Medicated Confectionery Market, by Distribution Channel
9. Americas Medicated Confectionery Market
10. Asia-Pacific Medicated Confectionery Market
11. Europe, Middle East & Africa Medicated Confectionery Market
12. Competitive Landscape
13. Competitive Portfolio
14. Appendix
List of Figures
List of Tables
Companies Mentioned
- A.L.Simpkin & Co. Ltd.
- Baker Perkins Limited by Schenck Process Group
- Bartek Ingredients Inc.
- Cargill, Inc.
- Creasy Foods Ltd.
- Enorama Pharma AB
- Ernest Jackson Ltd.
- GelStat Corporation
- Glanbia PLC
- Hamac Food Industries Sdn Bhd
- Herbion International Inc. by Kehkashan Group
- Lofthouse of Fleetwood Ltd.
- Lozen Pharma Pvt. Ltd.
- Lozy's pharmaceuticals, S.L.
- Mars Incorporated
- Mondelez International, Inc.
- Nestlé S.A. BY Ferrero International S.A.
- Perfetti Van Melle Group B.V.
- Piedmont Candy Company
- Prince Group
- Reckitt Benckiser Group PLC
- Skyepharma Production S.A.S.
- Swan Sweets Pvt. Ltd
- Syntegon Technology GmbH
- Tereos S.A.
- UHA Mikakuto Co.Ltd.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 185 |
| Published | March 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 6.28 Billion |
| Forecasted Market Value ( USD | $ 9.5 Billion |
| Compound Annual Growth Rate | 6.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 26 |
